GemPharmatech will be presenting two innovative research posters at the American Diabetes Association (ADA) 85th Scientific Sessions in Chicago, June 20–23, 2025.

Meet our team members, Dr. Jun Wang & Dr. Kevin Lominac, at these sessions:

● Sunday Jun 22, 2025 12:30 PM - 1:30 PM

A Persistent Hypertension Model Developed on the AGT Humanized Mice

Poster Number: 1858-LB

Location: Poster Hall (Hall F1)

● Sunday Jun 22, 2025 12:30 PM - 1:30 PM

Semaglutide and Lisinopril Exerts Therapeutic Benefits in a Genetically Engineered Diabetic Nephropathy Mouse Model

Poster Number: 1855-LB

Location: Poster Hall (Hall F1)

As experts in developing genetically engineered mouse models (with over 25,000 strains and counting), we’re proud to support metabolic disease research with cutting-edge models and advanced preclinical efficacy services.

Want to discuss our models or meet at ADA? Email us at sales@gempharmatech.com to schedule a conversation with us.

Looking forward to connecting in Chicago!